| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/14/2005 | WO2005040376A3 Method from the selection of biomolecules from biomolecule variant libraries |
| 07/14/2005 | WO2005038034A3 Plant transcriptional regulators of abiotic stress |
| 07/14/2005 | WO2005038033A8 Cloning of cytochrome p450 genes from nicotiana |
| 07/14/2005 | WO2005033274A3 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 07/14/2005 | WO2005026210A3 Therapeutic binding molecules |
| 07/14/2005 | WO2005023990A3 Trans-splicing mediated photodynamic therapy |
| 07/14/2005 | WO2005021583A3 METHODS FOR IDENTIFYING, TREATING, AND INDUCING INFERTILITY USING SMC1β |
| 07/14/2005 | WO2005016274A3 Rnai treatment of eye disease |
| 07/14/2005 | WO2005014828A3 Process for the production of fine chemicals in plants |
| 07/14/2005 | WO2005014822A3 Novel therapeutic fusion proteins |
| 07/14/2005 | WO2005010149A3 Subgroup b adenoviral vectors for treating disease |
| 07/14/2005 | WO2005010144A3 Displacing a plasmid in a bacterial population |
| 07/14/2005 | WO2005003165A3 Cytokine variant polypeptides |
| 07/14/2005 | WO2005001063A3 Polynucleotides capable of target-dependent circularization and topological linkage |
| 07/14/2005 | WO2004092349A3 Plant cells and plants with increased tolerance to environmental stress |
| 07/14/2005 | WO2004078939A3 REGULATION OF Mdm2 FUNCTION |
| 07/14/2005 | WO2004063024A3 Floral packaging material having prints thereon |
| 07/14/2005 | WO2004060270A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/14/2005 | WO2004017923A3 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 07/14/2005 | WO2003029424A3 Novel proteins and nucleic acids encoding same |
| 07/14/2005 | WO2002097062A3 Recombinant narbonolide polyketide synthase |
| 07/14/2005 | WO2002083862A3 Methods and compositions for identifying disease genes using nonsense-mediated decay inhibition |
| 07/14/2005 | US20050155122 Strawberry plant and fruit named "La Cle des Champs" |
| 07/14/2005 | US20050155119 Chlorophyllous totipotent cell cultures |
| 07/14/2005 | US20050155117 Transcriptional regulation of plant disease tolerance |
| 07/14/2005 | US20050155116 Propagating perennial trees via callus culture comprising thidiazuron; tissue engineering and re-forestation; tree farms |
| 07/14/2005 | US20050155115 Use of Nitric Oxide Modulators in Agrobacterium-mediated Plant Transformation |
| 07/14/2005 | US20050155114 Stress-inducible plant promoters |
| 07/14/2005 | US20050155113 Expression vector comprising nucleotide sequences coding norwalk virus capsid protein for use in generating vaccine for prevention and treatment of gastrointestinal disorders |
| 07/14/2005 | US20050155112 Insecticidal protein for use as tool in preventing and controlling corn root worm infestation; biological pest control |
| 07/14/2005 | US20050155111 Methods for increasing the frequency of apomixis expression in angiosperms |
| 07/14/2005 | US20050155110 Eukaryotic initiation factor 5A (eIF-5A) for use as tool in identifying modulators which prevent browning in plants; controlling aging in plants; enzyme inhibitors; storage stability; enhamced shelf life |
| 07/14/2005 | US20050155109 Ethyl methanesulfonate generated tomato plant, fruits, seeds, parts and progeny comprising defective deoxyhypusine generating enzyme for use propagating plants with delayed senescence; age resistance; storage stability; enhanced shelf life |
| 07/14/2005 | US20050155108 Maize cellulose synthases and uses thereof |
| 07/14/2005 | US20050155107 Sugar and lipid metabolism regulators in plants VI |
| 07/14/2005 | US20050155106 Polynucleotide molecules for regulating gene expression of heterologous polynucleotide molecules in plants |
| 07/14/2005 | US20050155105 Increasing salt tolerance in plants by overexpression of vacuolar Na+/H+ transporters |
| 07/14/2005 | US20050155104 Toxin complex proteins and genes from Xenorhabus bovienii |
| 07/14/2005 | US20050155103 Transgenic plants expressing lepidopteran-active delta-endotoxins |
| 07/14/2005 | US20050155102 Methods and compositions for altering the functional properties of seed storage proteins in soybean |
| 07/14/2005 | US20050155101 System for transforming plants |
| 07/14/2005 | US20050155099 Propagating hepatitis c viral particles via culturing infected hepatocytes under reduced oxygen conditions; bioreactors |
| 07/14/2005 | US20050155098 Expression vector comprising reporter gene for as tool to establish stable supply of fluorescent fish with desired transgenes; bioreactor for heterologous gene expression |
| 07/14/2005 | US20050155097 Recombinant rodents comprising expression vector coding a toxin and somatotropin for use as tools in the study of pathologies and treatments relating to tissues and organ systems that typically contain eosinophils |
| 07/14/2005 | US20050155095 Porcine Isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region |
| 07/14/2005 | US20050155094 Expression vector comprising nucleotide sequences coding human recombination activating protein (RAG-1) gene for use as tool in generating immunodeficient pigs; animal models and immunotherapy |
| 07/14/2005 | US20050155093 Using embryo transfer to generate modified animal model; tissue engineering; bioreactor for heterologous protein expression |
| 07/14/2005 | US20050155092 Mutant muscle protein nucleotide sequences for use in generating animal models for diagnosis and treatment of cardiovascular disorders |
| 07/14/2005 | US20050155091 Protein kinase gamma (Prkag3 ) regulator sequences for use as tool in directing heterologous gene expression and proteins for treatment of diabetes, obesity, insulin resistance and dyslipidemia |
| 07/14/2005 | US20050155089 Transport protein for use in identifying modulators for prevention and treatment of inflammation, cardiovascular, neurological, reproductive and developmental disorders |
| 07/14/2005 | US20050155088 Ralstonia ahl-acylase gene |
| 07/14/2005 | US20050155087 Method of screening compounds |
| 07/14/2005 | US20050154197 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/14/2005 | US20050154191 Cat immunisation vectors |
| 07/14/2005 | US20050154190 compounds obtained by the screening of the present invention are useful as agents for the prevention/treatment of, for example, neurodegenerative diseases, immunological diseases, edema, acid indigestion, etc. |
| 07/14/2005 | US20050154187 Especially fused to dihydrofolate reductase, used for treating diseases marked by increased angiogenesis; also polynucleotides encoding the polypeptide and use of the polynucleotides in gene therapy. |
| 07/14/2005 | US20050153935 Compound and method for treating androgen-independent prostate cancer |
| 07/14/2005 | US20050153926 Method for the immobilization of oligonucleotides |
| 07/14/2005 | US20050153924 Antisense modulation of interferon gamma receptor 2 |
| 07/14/2005 | US20050153922 MutS homolog 5 (MSH5); gene expression inhibition; for modulation of fertility |
| 07/14/2005 | US20050153921 Methods of using mammalian RNase H and compositions thereof |
| 07/14/2005 | US20050153920 Ribozymes used as prodrugs |
| 07/14/2005 | US20050153919 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 07/14/2005 | US20050153918 Purified short interference RNA; for neoplastic treatment; kits |
| 07/14/2005 | US20050153917 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 07/14/2005 | US20050153916 Each strand of the siNA molecule is 18 to 23 nucleotides in length; and one strand comprises a nucleotide sequence having sufficient complementarity to telomerase RNA for the siNA molecule to direct cleavage of the RNA via RNA interference. |
| 07/14/2005 | US20050153915 RNA interference mediated inhibition of early growth response gene expression using short interfering nucleic acid (siNA) |
| 07/14/2005 | US20050153914 RNA interference mediated inhibition of MDR P-glycoprotein gene expression using short interfering nucleic acid (siNA) |
| 07/14/2005 | US20050153913 Nucleic acid carrier compositions and methods for their synthesis |
| 07/14/2005 | US20050153912 Antiviral oligonucleotides targeting viral families |
| 07/14/2005 | US20050153911 Antisense modulation of extracellular-signal-regulated kinase-6 expression |
| 07/14/2005 | US20050153910 Antibody and inhibitor and transformation method and transformation kit using the same |
| 07/14/2005 | US20050153909 Producing a cell that contains heterologous nucleic acid byintroducing a satellite artificial chromosome (SATAC) into the cell |
| 07/14/2005 | US20050153891 proteins coded by murine herpes viruses, or homologues, use in binding chemokines, to produce an immunomodulatory or antiinflammatory effects |
| 07/14/2005 | US20050153890 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/14/2005 | US20050153888 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/14/2005 | US20050153886 nucleotide sequences comprising cDNA and genomic DNA that code for angiogenesis factors, used for gene therapy |
| 07/14/2005 | US20050153878 Fgfr agonists |
| 07/14/2005 | US20050153451 Intravascular delivery of non-viral nucleic acid |
| 07/14/2005 | US20050153450 Using vector transformation to generate trangenic cells capable of expressing viral sequences and propagate recombinant viral particles |
| 07/14/2005 | US20050153449 Method for producing insulin-secreting stem cells and cells derived therefrom |
| 07/14/2005 | US20050153448 Fungal beta-glucuronidase genes and gene products |
| 07/14/2005 | US20050153445 System for expanding and differentiating human embryonic stem cells |
| 07/14/2005 | US20050153444 Using fibroblast growth factor to establish a line of embryonic stem cells |
| 07/14/2005 | US20050153442 Adipose-derived stem cells and lattices |
| 07/14/2005 | US20050153441 Adipose-derived stem cells and lattices |
| 07/14/2005 | US20050153440 Using embryonic germ cell as model for monittoring and evaluating genomic imprinting; tissue engineering; tissue targeted therapy; regenerative medicine; gene silencing |
| 07/14/2005 | US20050153437 Method for controlling biological function with mechanical vibration and device therefor |
| 07/14/2005 | US20050153430 Automatic continuous processing during nucleic acid amplification |
| 07/14/2005 | US20050153420 Methods of adenovirus purification |
| 07/14/2005 | US20050153419 Host cells designed for efficient propagation and recovering of viral particles |
| 07/14/2005 | US20050153417 Halohydrin dehalogenases and related polynucleotides |
| 07/14/2005 | US20050153416 Anticancer agents |
| 07/14/2005 | US20050153415 Lysin for use as tool in prevention of clostridial infection |
| 07/14/2005 | US20050153414 Regulator of G-protein signaling (RGS) polypeptide for use as tools in identifying modulators of cell signaling; antitumor agents; mimetics |
| 07/14/2005 | US20050153413 Type II thioesterase from streptomyces coelicolor a3(2) and the coding sequence |
| 07/14/2005 | US20050153407 Chemoenzymatic methods for the synthesis of statins and stain intermediates |
| 07/14/2005 | US20050153405 Such as 4-(Indol-3-ylmethyl)-4-hydroxy-2-oxoglutarate from indole pyruvic acid and pyruvic acid (and/or oxaloacetic acid) by aldolase derived from Pseudomonas, Erwinia, Flavobacterium, and/or Xanthomonas |
| 07/14/2005 | US20050153404 Anti-kazlauskas lipases |
| 07/14/2005 | US20050153399 Introducing a DNA construct into a filamentous fungal cell, culturing the filamentous fungal cell under suitable culture conditions to allow expression of the heterologous DNA sequence, and producing the protease inhibitor |